Recapping 2023 Interviews With Leading Experts in Dermatology

LIGHTFIELD STUDIOS/Adobe Stock

Neal Bhatia, MD

Managing Office Politics and Clinical Negotiations With Neal Bhatia, MD

Bhatia shares key pearls from his sessions at AAD 2023 discussing office politics and how to run a clinical research unit.

What You Need to Know About JAKs, TYKs, and Clinical Trials

Neal Bhatia, MD, will guide attendees at Fall Clinical PA & NP on the difference between JAKs and TYKs, as well as the role of PAs and NPs in clinical research.

Neal Bhatia, MD: What Clinicians Need to Know About Actinic Keratosis

Bhatia also shared insights into ritlecitinib for alopecia areata at Fall Clinical 2023.

Renata Block, MMS, PA-C

Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs

Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.

Renata Block, MMS, PA-C: When We Collaborate, The Patient Wins

Renata Block, MMS, PA-C, delves into the important and ever-evolving role of physician assistants in dermatology.

Renata Block, PA-C, Reflects on Dermatology Innovations in 2023

2023 was full of advancements in both medical and cosmetic dermatology, and 2024 is shaping up to be just as exciting.

Christopher Bunick, MD, PhD

Molecular Differentiation of Dermatologic Therapeutics With Christopher Bunick, MD, PhD

Bunick presented 3 sessions at the 2023 World Congress of Dermatology meeting in Singapore.

Christopher Bunick, MD, PhD, Discusses Benzene Contamination in Personal Care Products and Why It Keeps Happening

Aerosolized dry shampoo is the latest personal care product to contain detectable levels of benzene, according to Bunick’s SCALE 2023 session.

Adding Cabtreo to the Acne Vulgaris Tool Box

Christopher Bunick, MD, PhD, reviews Cabtreo’s recent FDA approval and what the new triple-combination gel means for acne patients.

Raj Chovatiya, MD, PhD

Kidney Disease-Associated Pruritus and Managing Prurigo Nodularis: Treatment Pearls From Raj Chovatiya, MD, PhD

As the 25th World Congress of Dermatology winds down this week, Chovatiya shares highlights from his sessions in Singapore.

4 For 4 Sessions With Raj Chovatiya, MD, PhD, Present Range of Dermatology Challenges and Opportunities

He delves into one of his most challenging recent cases, the evolution of treatment options, and strategies to think outside of the box in diagnostic and therapeutic approaches.

Upadacitinib, Long-Term Control, and Tapinarof, Oh My!

Raj Chovatiya, MD, PhD, discusses highlights from his sessions at RAD 2023 on best practices for AD management.

James Del Rosso, DO

Acne & Rosacea, Drug Actions, and Atopic Dermatitis Updates With James Del Rosso, DO

Del Rosso previews his upcoming sessions at SCALE 2023 discussing the latest updates in management and treatment techniques.

Previewing Fall Clinical PA & NP Conference With James Del Rosso, DO

As senior director, Del Rosso is looking forward to presenting numerous sessions and welcoming attendees to Orlando.

Delving Into Fall Clinical 2023 With Del Rosso

One of the many minds behind innovative Fall Clinical Dermatology sessions gives a sneak peek of the top 5 things to look forward to during this year's meeting.

Joslyn Kirby, MD

Recognizing and Treating Hidradenitis Suppurativa With Joslyn Kirby, MD

Joslyn Kirby, MD, discusses the importance of awareness and recognition in hidradenitis suppurativa from a clinician and patient perspective.

Joslyn Kirby, MD, Shares OTC Product Benefits and HS Procedural Pearls

Kirby presented at both Fall Clinical and the Inflammatory Disease Summit in Las Vegas.

Shawn Kwatra, MD

Shawn Kwatra, MD, Reviews Late-Breaking Data of Abrocitinib for Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Kwatra presented the abrocitinib data at EADV 2023.

Shawn Kwatra, MD: Managing Prurigo Nodularis With Biologics

Kwatra reviewed skin lesions in PN and important treatment considerations for patients at Fall Clinical.

Nemolizumab Significantly Reduces Itch and Improves DLQI in Patients With Prurigo Nodularis

Shawn Kwatra, MD, shares his thoughts on the positive phase 3 data of OLYMPIA 2.

Shawn Kwatra, MD, Shares Highlights From the 12th World Congress on Itch

Kwatra presented on the unmet need for itch improvement in patients with skin of color.

Mark Lebwohl, MD

New and Promising Drugs in Inflammatory Dermatoses

Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."

Mark Lebwohl, MD: The Evolving Treatment Landscape of IL-17 Inhibitors

Mark Lebwohl, MD, spoke with Dermatology Times about his talk on IL-17 inhibitors.

Orit Markowitz, MD

Orit Markowitz, MD: Cutting Edge Dermatology - Without Cutting the Skin

Orit Markowitz, MD, discusses pearls her SDPA fall conference sessions, "Melanoma Diagnosis, Outcomes and Survival," and "Advanced Conditions."

The Future of Non-Invasive Skin Cancer Removal

Orit Markowitz, MD, discusses the future of non-invasive lasers in removing skin cancer and cancerous lesions, ultimately allowing patients to leave the practice without a bandaid.

Jane Mast, PhD, DMSc, MPAS

Jane Mast, PhD, DMSc, MPAS: Having a Passion for Patients

Mast spoke with Dermatology Times about her conference workshop, what she's looking forward to ahead of this week's SDPA conference, and the importance of always maintaining a passion for patients.

Jane Mast, PhD, DMSc, MPAS: Empathy in the Patient Journey With HS

Jane Mast, PhD, DMSc, MPAS, discusses empathetic care in hidradenitis suppurativa and the importance of supporting patients with HS in every step of their journey with the condition.

Shanna Miranti, MPAS, PA-C

Shanna Miranti, MPAS, PA-C, Shares Insights on Newly Approved VP-102 for Molluscum Contagiosum

Providers have been eagerly awaiting the approval of VP-102, as molluscum contagiosum accounts for approximately 1% of all diagnosed skin conditions.

The Role of Dermatology Advanced Practice Providers With Shanna Miranti, PA-C

Dermatology advanced practice providers work alongside physicians to improve patient care and access.

Arash Mostaghimi, MD, MPA, MPH

Arash Mostaghimi, MD, MPA, MPH: Pearls in Dermatopathology and Alopecia

Arash Mostaghimi, MD, MPA, MPH, provides a comprehensive overview of his SDPA conference sessions, "Understanding the Pathology Report and Basic Biopsies," "Beyond the H&E," and "Alopecia: Treating Challenging Cases."

Looking Ahead to the Future of Dermatology

As SDPA summer sessions have concluded, Arash Mostaghimi, MD, MPA, MPH, delves into what lies ahead in the dermatology industry—including the importance of collaboration between physicians and PAs.

Omar Noor, MD, FAAD

Discussing Clinical Pearls in Dermatology With Omar Noor, MD, FAAD

Omar Noor, MD, FAAD, discusses his SDPA session, "Clinical Pearls for Pediatric and Adult Dermatology."

Emphasizing Culturally Competent Care in Patients With Skin of Color

Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.

Jonathan Silverberg, MD, PhD, MPH

Jonathan Silverberg Discusses Role of Environment on Atopic Dermatitis

Silverberg discusses how certain irritants and living situations may cause flares in patients with atopic dermatitis.

Systemic Treatment, Immunosuppressants, and JAK Inhibitor Session Highlights

Jonathan Silverberg, MD, PhD, MPH, shares highlights and key takeaways from his RAD 2023 sessions.

Jonathan Silverberg, MD, Previews Upcoming Virtual RAD Conference and Exciting Topics

This year’s virtual atopic dermatitis conference takes place on Sunday, December 10, 2023.

Lisa Swanson, MD, PhD

Lisa Swanson, MD, PhD: Clinical Pearls in Pediatric Dermatology

Lisa Swanson, MD, PhD, delves into clinical pearls from her SDPA fall conference sessions on infantile hemangiomas and challenging cases in pediatric dermatology.

Molluscum Contagiosum With Elizabeth (Lisa) Swanson, MD: Tackling a Nuisance

Treatment is not mandatory and, in fact, clinicians are still without an FDA-approved treatment option, but parents often insist on some sort of action.

Want to be interviewed by Dermatology Times to share your research, insights, and more? Reach out to our team at DTEditor@mmhgroup.com.